{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["chemoprevention", "health disparity", "medicinal plant", "prostate cancer"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30720759", "DateCompleted": {"Year": "2019", "Month": "03", "Day": "29"}, "DateRevised": {"Year": "2023", "Month": "10", "Day": "06"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "02", "Day": "04"}], "Language": ["eng"], "ELocationID": ["336", "10.3390/nu11020336"], "Journal": {"ISSN": "2072-6643", "JournalIssue": {"Volume": "11", "Issue": "2", "PubDate": {"Year": "2019", "Month": "Feb", "Day": "04"}}, "Title": "Nutrients", "ISOAbbreviation": "Nutrients"}, "ArticleTitle": "Prostate Cancer Disparity, Chemoprevention, and Treatment by Specific Medicinal Plants.", "Abstract": {"AbstractText": ["Prostate cancer (PC) is one of the most common cancers in men. The global burden of this disease is rising. Its incidence and mortality rates are higher in African American (AA) men compared to white men and other ethnic groups. The treatment decisions for PC are based exclusively on histological architecture, prostate-specific antigen (PSA) levels, and local disease state. Despite advances in screening for and early detection of PC, a large percentage of men continue to be diagnosed with metastatic disease including about 20% of men affected with a high mortality rate within the African American population. As such, this population group may benefit from edible natural products that are safe with a low cost. Hence, the central goal of this article is to highlight PC disparity associated with nutritional factors and highlight chemo-preventive agents from medicinal plants that are more likely to reduce PC. To reach this central goal, we searched the PubMed Central database and the Google Scholar website for relevant papers. Our search results revealed that there are significant improvements in PC statistics among white men and other ethnic groups. However, its mortality rate remains significantly high among AA men. In addition, there are limited studies that have addressed the benefits of medicinal plants as chemo-preventive agents for PC treatment, especially among AA men. This review paper addresses this knowledge gap by discussing PC disparity associated with nutritional factors and highlighting the biomedical significance of three medicinal plants (curcumin, garlic, and <i>Vernonia amygdalina</i>) that show a great potential to prevent/treat PC, as well as to reduce its incidence/prevalence and mortality, improve survival rate, and reduce PC-related health disparity."]}, "AuthorList": [{"Identifier": ["0000-0002-9582-7507"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Chemotherapeutics Research Laboratory, NIH/NIMHD RCMI-Center for Environmental Health, College of Science, Engineering and Technology, Jackson State University, 1400 Lynch Street, Jackson, MS 39217, USA. clement.yedjou@jsums.edu."}], "LastName": "Yedjou", "ForeName": "Clement G", "Initials": "CG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Chemotherapeutics Research Laboratory, NIH/NIMHD RCMI-Center for Environmental Health, College of Science, Engineering and Technology, Jackson State University, 1400 Lynch Street, Jackson, MS 39217, USA. arianeng6@gmail.com."}], "LastName": "Mbemi", "ForeName": "Ariane T", "Initials": "AT"}, {"Identifier": ["0000-0002-3192-5132"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, College of Science, Engineering and Technology, Jackson State University, 1400 Lynch Street, Jackson, MS 39217, USA. felicite.noubissi_kamdem@jsums.edu."}], "LastName": "Noubissi", "ForeName": "Felicite", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, University of Mississippi, 214 Shoemaker Hall, P.O. Box 1848, MS 38677, USA. 0solanget@gmail.com."}], "LastName": "Tchounwou", "ForeName": "Solange S", "Initials": "SS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Animal Biology, Higher Institute of Environmental Sciences, Yaounde P.O.Box 16317, Cameroon. tsabang2001@yahoo.fr."}], "LastName": "Tsabang", "ForeName": "Nole", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center of Excellence in Minority Health and Health Disparities, School of Public Health, Jackson State University, Jackson Medical Mall-Thad Cochran Center, 350 West Woodrow Wilson Avenue, Jackson, MS 39213, USA. marinelle.payton@jsums.edu."}], "LastName": "Payton", "ForeName": "Marinelle", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Genetics, LSU Health Sciences Center, School of Medicine, 533 Bolivar Street, Room 657, New Orleans, LA 70112, USA. lmiele@lsuhsc.edu."}], "LastName": "Miele", "ForeName": "Lucio", "Initials": "L"}, {"Identifier": ["0000-0002-3407-6674"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, College of Science, Engineering and Technology, Jackson State University, 1400 Lynch Street, Jackson, MS 39217, USA. paul.b.tchounwou@jsums.edu."}], "LastName": "Tchounwou", "ForeName": "Paul B", "Initials": "PB"}], "GrantList": [{"GrantID": "U54 GM104940", "Acronym": "GM", "Agency": "NIGMS NIH HHS", "Country": "United States"}, {"GrantID": "U54 MD008149", "Acronym": "MD", "Agency": "NIMHD NIH HHS", "Country": "United States"}, {"GrantID": "G12MD007581", "Acronym": "NH", "Agency": "NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Nutrients", "NlmUniqueID": "101521595", "ISSNLinking": "2072-6643"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anticarcinogenic Agents"}, {"RegistryNumber": "IT942ZTH98", "NameOfSubstance": "Curcumin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["statistics & numerical data"], "DescriptorName": "Black or African American"}, {"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Anticarcinogenic Agents"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Curcumin"}, {"QualifierName": [], "DescriptorName": "Garlic"}, {"QualifierName": [], "DescriptorName": "Health Status Disparities"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["methods"], "DescriptorName": "Phytotherapy"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["ethnology", "mortality", "prevention & control"], "DescriptorName": "Prostatic Neoplasms"}, {"QualifierName": [], "DescriptorName": "Vernonia"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Ferlay J., Parkin D.M., Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur. J. Cancer. 2010;46:765\u2013781. doi: 10.1016/j.ejca.2009.12.014.", "ArticleIdList": ["10.1016/j.ejca.2009.12.014", "20116997"]}, {"Citation": "Siegel R., Miller K., Jemal A. Cancer statistics, 2015. CA Cancer J. Clin. 2015;65:29. doi: 10.3322/caac.21254.", "ArticleIdList": ["10.3322/caac.21254", "25559415"]}, {"Citation": "Ferraldeschi R., Pezaro C., Karavasilis V., de Bono J. Abiraterone and Novel Antiandrogens: Overcoming Castration Resistance in Prostate Cancer. Annu. Rev. Med. 2013;64:1\u201313. doi: 10.1146/annurev-med-121211-091605.", "ArticleIdList": ["10.1146/annurev-med-121211-091605", "23020876"]}, {"Citation": "Roudier M.P., True L.D., Higano C.S., Vesselle H., Ellis W., Lange P., Vessella R.L. Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone. Hum. Pathol. 2003;34:646\u2013653. doi: 10.1016/S0046-8177(03)00190-4.", "ArticleIdList": ["10.1016/S0046-8177(03)00190-4", "12874759"]}, {"Citation": "Pagliarulo V. Androgen Deprivation Therapy for Prostate Cancer. Adv. Exp. Med. Biol. 2018 in press.", "ArticleIdList": ["30324345"]}, {"Citation": "Watson P.A., Arora V.K., Sawyers C.L. Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer. Nat. Rev. Cancer. 2015;15:701\u2013711. doi: 10.1038/nrc4016.", "ArticleIdList": ["10.1038/nrc4016", "PMC4771416", "26563462"]}, {"Citation": "Pelekanou V., Castanas E. Androgen Control in Prostate Cancer. J. Cell. Biochem. 2016;117:2224\u20132234. doi: 10.1002/jcb.25572.", "ArticleIdList": ["10.1002/jcb.25572", "27104784"]}, {"Citation": "Teply B.A., Antonarakis E.S. Novel mechanism-based therapeutics for androgen axis blockade in castration-resistant prostate cancer. Curr. Opin. Endocrinol. Diabetes Obes. 2016;23:279\u2013290. doi: 10.1097/MED.0000000000000254.", "ArticleIdList": ["10.1097/MED.0000000000000254", "PMC4896735", "26978733"]}, {"Citation": "Shahinian V.B., Kuo Y.F., Freeman J.L., Goodwin J.S. Risk of the \u201candrogen deprivation syndrome\u201d in men receiving androgen deprivation for prostate cancer. Arch. Intern. Med. 2006;166:465\u2013471.", "ArticleIdList": ["PMC2222554", "16505268"]}, {"Citation": "Nead K.T., Gaskin G., Chester C., Swisher-McClure S., Leeper N.J., Shah N.H. Association between androgen deprivation therapy and risk of dementia. JAMA Oncol. 2017;3:49\u201355. doi: 10.1001/jamaoncol.2016.3662.", "ArticleIdList": ["10.1001/jamaoncol.2016.3662", "27737437"]}, {"Citation": "Viani G.A., Bernardes Da Silva L.G., Stefano E.J. Prevention of gynecomastia and breast pain caused by androgen deprivation therapy in prostate cancer: Tamoxifen or radiotherapy? Int. J. Radiat. Oncol. Biol. Phys. 2012;83:e519\u2013e524. doi: 10.1016/j.ijrobp.2012.01.036.", "ArticleIdList": ["10.1016/j.ijrobp.2012.01.036", "22704706"]}, {"Citation": "Higano C.S. Bone loss and the evolving role of bisphosphonate therapy in prostate cancer. Urol. Oncol. Semin. Orig. Investig. 2003;21:392\u2013398. doi: 10.1016/S1078-1439(03)00143-1.", "ArticleIdList": ["10.1016/S1078-1439(03)00143-1", "14670551"]}, {"Citation": "Scher H.I., Fizazi K., Saad F., Taplin M.-E., Sternberg C.N., Miller K., de Wit R., Mulders P., Chi K.N., Shore N.D., et al. Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy - Supplementary Appendix. N. Engl. J. Med. 2012;367:1187\u20131197. doi: 10.1056/NEJMoa1207506.", "ArticleIdList": ["10.1056/NEJMoa1207506", "22894553"]}, {"Citation": "Fizazi K., Scher H.I., Molina A., Logothetis C.J., Chi K.N., Jones R.J., Staffurth J.N., North S., Vogelzang N.J., Saad F., et al. Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: Final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study. Lancet Oncol. 2012;13:983\u2013992. doi: 10.1016/S1470-2045(12)70379-0.", "ArticleIdList": ["10.1016/S1470-2045(12)70379-0", "22995653"]}, {"Citation": "Fletcher R.H., Fairfield K.M. Vitamins for chronic disease prevention in adults: Clinical applications. JAMA. 2002;287:3127\u20133129. doi: 10.1001/jama.287.23.3127.", "ArticleIdList": ["10.1001/jama.287.23.3127", "12069676"]}, {"Citation": "Reddy A., Kaelin W.G., Jr. Using cancer genetics to guide the selection of anticancer drug targets. Curr. Opin. Pharmacol. 2002;2:366\u2013373. doi: 10.1016/S1471-4892(02)00178-9.", "ArticleIdList": ["10.1016/S1471-4892(02)00178-9", "12127868"]}, {"Citation": "World Cancer Research Fund. American Institute for Cancer Research . Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. World Cancer Research Fund; London, UK: 2007."}, {"Citation": "Yedjou C., Tchounwou P., Payton M., Miele L., Fonseca D., Lowe L., Alo R. Assessing the Racial and Ethnic Disparities in Breast Cancer Mortality in the United States. Int. J. Environ. Res. Public Health. 2017;14:486. doi: 10.3390/ijerph14050486.", "ArticleIdList": ["10.3390/ijerph14050486", "PMC5451937", "28475137"]}, {"Citation": "Syed D.N., Khan N., Afaq F., Mukhtar H. Chemoprevention of prostate cancer through dietary agents: Progress and promise. Cancer Epidemiol. Biomarkers Prev. 2007;16:2193\u20132203. doi: 10.1158/1055-9965.EPI-06-0942.", "ArticleIdList": ["10.1158/1055-9965.EPI-06-0942", "18006906"]}, {"Citation": "Soerjomataram I., Oomen D., Lemmens V., Oenema A., Benetou V., Trichopoulou A., Coebergh J.W., Barendregt J., De Vries E. Increased consumption of fruit and vegetables and future cancer incidence in selected European countries. Eur. J. Cancer. 2010;46:2563\u20132580. doi: 10.1016/j.ejca.2010.07.026.", "ArticleIdList": ["10.1016/j.ejca.2010.07.026", "20843486"]}, {"Citation": "Turati F., Rossi M., Pelucchi C., Levi F., La Vecchia C. Fruit and vegetables and cancer risk: A review of southern European studies. Br. J. Nutr. 2015;113:S102\u2013S110. doi: 10.1017/S0007114515000148.", "ArticleIdList": ["10.1017/S0007114515000148", "26148912"]}, {"Citation": "Mart\u00ednez M.E., Jacobs E.T., Baron J.A., Marshall J.R., Byers T. Dietary supplements and cancer prevention: Balancing potential benefits against proven harms. J. Natl. Cancer Inst. 2012;104:732\u2013739. doi: 10.1093/jnci/djs195.", "ArticleIdList": ["10.1093/jnci/djs195", "PMC3352833", "22534785"]}, {"Citation": "Bjelakovic G., Nikolova D., Gluud L.L., Simonetti R.G., Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Sao Paulo Med. J. 2015;133:164. doi: 10.1590/1516-3180.20151332T1.", "ArticleIdList": ["10.1590/1516-3180.20151332T1", "PMC10496628", "26018887"]}, {"Citation": "Ochwang\u2019i D.O., Kimwele C.N., Oduma J.A., Gathumbi P.K., Mbaria J.M., Kiama S.G. Medicinal plants used in treatment and management of cancer in Kakamega County, Kenya. J. Ethnopharmacol. 2014;151:1040\u20131055. doi: 10.1016/j.jep.2013.11.051.", "ArticleIdList": ["10.1016/j.jep.2013.11.051", "24362078"]}, {"Citation": "Sivaraj R., Rahman P.K.S.M., Rajiv P., Narendhran S., Venckatesh R. Biosynthesis and characterization of Acalypha indica mediated copper oxide nanoparticles and evaluation of its antimicrobial and anticancer activity. Spectrochim. Acta Part. A Mol. Biomol. Spectrosc. 2014;129:25\u2013258. doi: 10.1016/j.saa.2014.03.027.", "ArticleIdList": ["10.1016/j.saa.2014.03.027", "24747845"]}, {"Citation": "Mothupi M.C. Use of herbal medicine during pregnancy among women with access to public healthcare in Nairobi, Kenya: A cross-sectional survey. BMC Complement. Altern. Med. 2014;14 doi: 10.1186/1472-6882-14-432.", "ArticleIdList": ["10.1186/1472-6882-14-432", "PMC4230355", "25370478"]}, {"Citation": "Rao P.V., Nallappan D., Madhavi K., Rahman S., Jun Wei L., Gan S.H. Phytochemicals and Biogenic Metallic Nanoparticles as Anticancer Agents. Oxid. Med. Cell. Longev. 2016;2016 doi: 10.1155/2016/3685671.", "ArticleIdList": ["10.1155/2016/3685671", "PMC4781993", "27057273"]}, {"Citation": "Tavakoli J., Miar S., Zadehzare M.M., Akbari H. Evaluation of effectiveness of herbal medication in cancer care: A review study. Iran J. Cancer Prev. 2012;5:144\u2013156.", "ArticleIdList": ["PMC4294537", "25628834"]}, {"Citation": "Wheat J., Currie G. Herbal medicine for cancer patients: An evidence based review. Internet J. Altern. Med. 2008;5:5."}, {"Citation": "Jemal A., Siegel R., Xu J., Ward E. Cancer statistics, 2010. CA Cancer J. Clin. 2010;60:277\u2013300. doi: 10.3322/caac.20073.", "ArticleIdList": ["10.3322/caac.20073", "20610543"]}, {"Citation": "Ward E., Jemal A., Cokkinides V., Singh G.K., Cardinez C., Ghafoor A., Thun M. Cancer Disparities by Race/Ethnicity and Socioeconomic Status. CA. Cancer J. Clin. 2004;54:78\u201393. doi: 10.3322/canjclin.54.2.78.", "ArticleIdList": ["10.3322/canjclin.54.2.78", "15061598"]}, {"Citation": "Underwood W., DeMonner S., Ubel P., Fagerlin A., Sanda M.G., Wei J.T. Racial/ethnic disparities in the treatment of localized/regional prostate cancer. J. Urol. 2004;171:1504\u20131507. doi: 10.1097/01.ju.0000118907.64125.e0.", "ArticleIdList": ["10.1097/01.ju.0000118907.64125.e0", "15017208"]}, {"Citation": "Gross C.P., Smith B.D., Wolf E., Andersen M. Racial disparities in cancer therapy: Did the gap narrow between 1992 and 2002? Cancer. 2008;112:900\u2013908. doi: 10.1002/cncr.23228.", "ArticleIdList": ["10.1002/cncr.23228", "PMC3535295", "18181101"]}, {"Citation": "Chu K.C., Tarone R.E., Freeman H.P. Trends in prostate cancer mortality among black men and white men in the United States. Cancer. 2003;97:1507\u20131516. doi: 10.1002/cncr.11212.", "ArticleIdList": ["10.1002/cncr.11212", "12627516"]}, {"Citation": "Ghafoor A., Jemal A., Cokkinides V., Cardinez C., Murray T., Samuels A., Thun M.J. Cancer statistics for African Americans. CA Cancer J. Clin. 2002;52:326\u2013341. doi: 10.3322/canjclin.52.6.326.", "ArticleIdList": ["10.3322/canjclin.52.6.326", "12469762"]}, {"Citation": "Rodriguez C., McCullough M.L., Mondul A.M., Jacobs E.J., Chao A., Patel A.V., Thun M.J., Calle E.E. Meat consumption among Black and White men and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol. Biomarkers Prev. 2006 doi: 10.1158/1055-9965.EPI-05-0614.", "ArticleIdList": ["10.1158/1055-9965.EPI-05-0614", "16492907"]}, {"Citation": "Amin M., Jeyaganth S., Fahmy N., B\u00e9gin L.R., Aronson S., Jacobson S., Tanguay S., Kassouf W., Aprikian A. Dietary habits and prostate cancer detection: A case-control study. Can. Urol. Assoc. J. 2008;2:510\u2013515. doi: 10.5489/cuaj.918.", "ArticleIdList": ["10.5489/cuaj.918", "PMC2572247", "18953447"]}, {"Citation": "American Cancer Society Cancer Facts & Figures 2013. Am. Cancer Soc. 2013 doi: 10.1002/ijc.27711.", "ArticleIdList": ["10.1002/ijc.27711"]}, {"Citation": "Kurahashi N., Iwasaki M., Inoue M., Sasazuki S., Tsugane S. Plasma isoflavones and subsequent risk of prostate cancer in a nested case-control study: The Japan Public Health Center. J. Clin. Oncol. 2008 doi: 10.1200/JCO.2008.16.8807.", "ArticleIdList": ["10.1200/JCO.2008.16.8807", "19018085"]}, {"Citation": "Kumar N.B., Kang L., Pow-Sang J., Xu P., Allen K., Riccardi D., Besterman-Dahan K., Krischer J.P. Results of a randomized phase I dose-finding trial of several doses of isoflavones in men with localized prostate cancer: Administration prior to radical prostatectomy. J. Soc. Integr. Oncol. 2010 doi: 10.2310/7200.2009.0024.", "ArticleIdList": ["10.2310/7200.2009.0024", "PMC3277948", "20205984"]}, {"Citation": "Amling C.L., Riffenburgh R.H., Sun L., Moul J.W., Lance R.S., Kusuda L., Sexton W.J., Soderdahl D.W., Donahue T.F., Foley J.P., et al. Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. J. Clin. Oncol. 2004 doi: 10.1200/JCO.2004.03.132.", "ArticleIdList": ["10.1200/JCO.2004.03.132", "14691120"]}, {"Citation": "Beebe-Dimmer J.L., Nock N.L., Neslund-Dudas C., Rundle A., Bock C.H., Tang D., Jankowski M., Rybicki B.A. Racial Differences in Risk of Prostate Cancer Associated With Metabolic Syndrome. Urology. 2009 doi: 10.1016/j.urology.2009.03.013.", "ArticleIdList": ["10.1016/j.urology.2009.03.013", "PMC2704922", "19428088"]}, {"Citation": "Gong Z., Neuhouser M.L., Goodman P.J., Albanes D., Chi C., Hsing A.W., Lippman S.M., Platz E.A., Pollak M.N., Thompson I.M., et al. Obesity, diabetes, and risk of prostate cancer: Results from the prostate cancer prevention trial. Cancer Epidemiol. Biomarkers Prev. 2006 doi: 10.1158/1055-9965.EPI-06-0477.", "ArticleIdList": ["10.1158/1055-9965.EPI-06-0477", "17035408"]}, {"Citation": "Spangler E., Zeigler-Johnson C.M., Coomes M., Malkowicz S.B., Wein A., Rebbeck T.R. Association of obesity with tumor characteristics and treatment failure of prostate cancer in African-American and European American men. J. Urol. 2007 doi: 10.1016/j.juro.2007.07.021.", "ArticleIdList": ["10.1016/j.juro.2007.07.021", "17868722"]}, {"Citation": "Fesinmeyer M.D., Gulati R., Zeliadt S., Weiss N., Kristal A.R., Etzioni R. Effect of population trends in body mass index on prostate cancer incidence and mortality in the United States. Cancer Epidemiol. Biomarkers Prev. 2009 doi: 10.1158/1055-9965.EPI-08-0784.", "ArticleIdList": ["10.1158/1055-9965.EPI-08-0784", "PMC2750884", "19258479"]}, {"Citation": "Putnam S.D., Cerhan J.R., Parker A.S., Bianchi G.D., Wallace R.B., Cantor K.P., Lynch C.F. Lifestyle and anthropometric risk factors for prostate cancer in a cohort of Iowa men. Ann. Epidemiol. 2000 doi: 10.1016/S1047-2797(00)00057-0.", "ArticleIdList": ["10.1016/S1047-2797(00)00057-0", "10964002"]}, {"Citation": "Sung J.F.C., Lin R.S., Pu Y.S., Chen Y.C., Chang H.C., Lai M.K. Risk factors for prostate carcinoma in Taiwan: A case-control study in a chinese population. Cancer. 1999 doi: 10.1002/(SICI)1097-0142(19990801)86:3<484::AID-CNCR17>3.0.CO;2-P.", "ArticleIdList": ["10.1002/(SICI)1097-0142(19990801)86:3<484::AID-CNCR17>3.0.CO;2-P", "10430257"]}, {"Citation": "Schuurman A.G., Goldbohm R.A., Dorant E., Van Den Brandt P.A. Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study. Am. J. Epidemiol. 2000 doi: 10.1093/oxfordjournals.aje.a010241.", "ArticleIdList": ["10.1093/oxfordjournals.aje.a010241", "10733035"]}, {"Citation": "Hsing A.W., Deng J., Sesterhenn I.A., Mostofi F.K., Stanczyk F.Z., Benichou J., Xie T., Gao Y.T. Body size and prostate cancer: A population-based case-control study in China. Cancer Epidemiol. Biomarkers Prev. 2000;9:12.", "ArticleIdList": ["11142419"]}, {"Citation": "Jonssoni F., Wolk A., Pedersen N.L., Lichtenstein P., Terry P., Ahlbom A., Feychting M. Obesity and hormone-dependent tumors: Cohort and co-twin control studies based on the Swedish Twin Registry. Int. J. Cancer. 2003 doi: 10.1002/ijc.11266.", "ArticleIdList": ["10.1002/ijc.11266", "12845658"]}, {"Citation": "Lee I.M., Sesso H.D., Paffenbarger R.S. A prospective cohort study of physical activity and body size in relation to prostate cancer risk (United States) Cancer Causes Control. 2001 doi: 10.1023/A:1008952528771.", "ArticleIdList": ["10.1023/A:1008952528771", "11246848"]}, {"Citation": "Rodriguez C., Freedland S.J., Deka A., Jacobs E.J., McCullough M.L., Patel A.V., Thun M.J., Calle E.E. Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol. Biomarkers Prev. 2007 doi: 10.1158/1055-9965.EPI-06-0754.", "ArticleIdList": ["10.1158/1055-9965.EPI-06-0754", "17179486"]}, {"Citation": "Giovannucci E., Rimm E.B., Liu Y., Leitzmann M., Wu K., Stampfer M.J., Willett W.C. Body mass index and risk of prostate cancer in U.S. health professionals. J. Natl. Cancer Inst. 2003 doi: 10.1093/jnci/djg009.", "ArticleIdList": ["10.1093/jnci/djg009", "12928350"]}, {"Citation": "Watters J.L., Park Y., Hollenbeck A., Schatzkin A., Albanes D. Cigarette smoking and prostate cancer in a prospective US cohort study. Cancer Epidemiol. Biomarkers Prev. 2009 doi: 10.1158/1055-9965.EPI-09-0252.", "ArticleIdList": ["10.1158/1055-9965.EPI-09-0252", "PMC2742569", "19706848"]}, {"Citation": "Huncharek M., Sue Haddock K., Reid R., Kupelnick B. Smoking as a risk factor for prostate cancer: A meta-analysis of 24 prospective cohort studies. Am. J. Public Health. 2010 doi: 10.2105/AJPH.2008.150508.", "ArticleIdList": ["10.2105/AJPH.2008.150508", "PMC2836346", "19608952"]}, {"Citation": "Centers for Disease Control and Prevention (CDC) Vital Signs: Current Cigarette Smoking among Adults Aged \u226518 Years with Mental Illness\u2014United States, 2009\u20132011. CDC; Atlanta, GA, USA: 2013. MMWR, Morb. Mortal. Wkly. Rep.", "ArticleIdList": ["PMC4604817", "23388551"]}, {"Citation": "Fu S.S., Burgess D., van Ryn M., Hatsukami D.K., Solomon J., Joseph A.M. Views on smoking cessation methods in ethnic minority communities: A qualitative investigation. Prev. Med. (Baltim). 2007 doi: 10.1016/j.ypmed.2006.11.002.", "ArticleIdList": ["10.1016/j.ypmed.2006.11.002", "17175016"]}, {"Citation": "Fu S.S., Kodl M.M., Joseph A.M., Hatsukami D.K., Johnson E.O., Breslau N., Wu B., Bierut L. Racial/ethnic disparities in the use of nicotine replacement therapy and quit ratios in lifetime smokers ages 25to 44 years. Cancer Epidemiol. Biomarkers Prev. 2008 doi: 10.1158/1055-9965.EPI-07-2726.", "ArticleIdList": ["10.1158/1055-9965.EPI-07-2726", "PMC2593846", "18583471"]}, {"Citation": "Trinidad D.R., P\u00e9rez-Stable E.J., White M.M., Emery S.L., Messer K. A nationwide analysis of US racial/ethnic disparities in smoking behaviors, smoking cessation, and cessation-related factors. Am. J. Public Health. 2011 doi: 10.2105/AJPH.2010.191668.", "ArticleIdList": ["10.2105/AJPH.2010.191668", "PMC3052356", "21330593"]}, {"Citation": "Levinson A.H., Borrayo E.A., Espinoza P., Flores E.T., P\u00e9rez-Stable E.J. An Exploration of Latino Smokers and the Use of Pharmaceutical Aids. Am. J. Prev. Med. 2006 doi: 10.1016/j.amepre.2006.03.022.", "ArticleIdList": ["10.1016/j.amepre.2006.03.022", "16829334"]}, {"Citation": "Murphy A.B., Akereyeni F., Nyame Y.A., Guy M.C., Martin I.K., Hollowell C.M.P., Walker K., Kittles R.A., Ahaghotu C. Smoking and prostate cancer in a multi-ethnic cohort. Prostate. 2013 doi: 10.1002/pros.22699.", "ArticleIdList": ["10.1002/pros.22699", "PMC3931574", "23824512"]}, {"Citation": "Scoccianti C., Cecchini M., Anderson A.S., Berrino F., Boutron-Ruault M.C., Espina C., Key T.J., Leitzmann M., Norat T., Powers H., et al. European Code against Cancer 4th Edition: Alcohol drinking and cancer. Cancer Epidemiol. 2015 doi: 10.1016/j.canep.2015.01.007.", "ArticleIdList": ["10.1016/j.canep.2015.01.007", "26115567"]}, {"Citation": "World Cancer Research Fund . For C.R. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. AICR; Washington, DC, USA: 2007."}, {"Citation": "Clarke G., Whittemore A.S. Prostate cancer risk in relation to anthropometry and physical activity: The National Health and Nutrition Examination Survey I Epidemiological Follow-Up Study. Cancer Epidemiol. Biomarkers Prev. 2000;9:875\u2013881.", "ArticleIdList": ["11008903"]}, {"Citation": "Moore S.C., Peters T.M., Ahn J., Park Y., Schatzkin A., Albanes D., Hollenbeck A., Leitzmann M.F. Age-specific physical activity and prostate cancer risk among white men and black men. Cancer. 2009 doi: 10.1002/cncr.24538.", "ArticleIdList": ["10.1002/cncr.24538", "PMC2767425", "19645029"]}, {"Citation": "World Health Organization GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. Globocan. 2012:1\u20136. doi: 10.1002/ijc.27711.", "ArticleIdList": ["10.1002/ijc.27711"]}, {"Citation": "Zhang J., Dhakal I.B., Zhao Z., Li L. Trends in mortality from cancers of the breast, colon, prostate, esophagus, and stomach in East Asia: Role of nutrition transition. Eur. J. Cancer Prev. 2012 doi: 10.1097/CEJ.0b013e328351c732.", "ArticleIdList": ["10.1097/CEJ.0b013e328351c732", "22357483"]}, {"Citation": "Hoffman R.M., Harlan L.C., Klabunde C.N., Gilliland F.D., Stephenson R.A., Hunt W.C., Potosky A.L. Racial Differences in Initial Treatment for Clinically Localized Prostate Cancer: Results from the Prostate Cancer Outcomes Study. J. Gen. Intern. Med. 2003 doi: 10.1046/j.1525-1497.2003.21105.x.", "ArticleIdList": ["10.1046/j.1525-1497.2003.21105.x", "PMC1494937", "14521648"]}, {"Citation": "Barocas D.A., Penson D.F. Racial variation in the pattern and quality of care for prostate cancer in the USA: Mind the gap. BJU Int. 2010 doi: 10.1111/j.1464-410X.2010.09467.x.", "ArticleIdList": ["10.1111/j.1464-410X.2010.09467.x", "PMC2910169", "20553251"]}, {"Citation": "American Cancer Society Cancer Facts & Figures 2018. Am. Cancer Soc. 2018 doi: 10.1182/blood-2015-12-687814.", "ArticleIdList": ["10.1182/blood-2015-12-687814"]}, {"Citation": "Brawley O.W., Jani A.B., Master V. Prostate Cancer and Race. Curr. Probl. Cancer. 2007 doi: 10.1016/j.currproblcancer.2007.01.006.", "ArticleIdList": ["10.1016/j.currproblcancer.2007.01.006", "17543949"]}, {"Citation": "Robbins A.S., Koppie T.M., Gomez S.L., Parikh-Patel A., Mills P.K. Differences in prognostic factors and survival among white and Asian men with prostate cancer, California, 1995\u20132004. Cancer. 2007 doi: 10.1002/cncr.22872.", "ArticleIdList": ["10.1002/cncr.22872", "17701951"]}, {"Citation": "Chhatre S., Bruce Malkowicz S., Sanford Schwartz J., Jayadevappa R. Understanding the Racial and Ethnic Differences in Cost and Mortality Among Advanced Stage Prostate Cancer Patients (STROBE) Medicine (Baltimore) 2015 doi: 10.1097/MD.0000000000001353.", "ArticleIdList": ["10.1097/MD.0000000000001353", "PMC4616711", "26266389"]}, {"Citation": "Willis M.S., Wians F.H. The role of nutrition in preventing prostate cancer: A review of the proposed mechanism of action of various dietary substances. Clin. Chim. Acta. 2003 doi: 10.1016/S0009-8981(03)00048-2.", "ArticleIdList": ["10.1016/S0009-8981(03)00048-2", "12636926"]}, {"Citation": "Cheng I., Witte J.S., McClure L.A., Shema S.J., Cockburn M.G., John E.M., Clarke C.A. Socioeconomic status and prostate cancer incidence and mortality rates among the diverse population of California. Cancer Causes Control. 2009 doi: 10.1007/s10552-009-9369-0.", "ArticleIdList": ["10.1007/s10552-009-9369-0", "PMC2746891", "19526319"]}, {"Citation": "Woods L.M., Rachet B., Coleman M.P. Origins of socio-economic inequalities in cancer survival: A review. Ann. Oncol. 2006 doi: 10.1093/annonc/mdj007.", "ArticleIdList": ["10.1093/annonc/mdj007", "16143594"]}, {"Citation": "Weinrich S.P., Reynolds W.A.J., Tingen M.S., Starr C.R. Barriers to prostate cancer screening. Cancer Nurs. 2000;23:117\u2013121. doi: 10.1097/00002820-200004000-00007.", "ArticleIdList": ["10.1097/00002820-200004000-00007", "10763282"]}, {"Citation": "Gilligan T. Social disparities and prostate cancer: Mapping the gaps in our knowledge. Cancer Causes Control. 2005;16:45\u201353. doi: 10.1007/s10552-004-1291-x.", "ArticleIdList": ["10.1007/s10552-004-1291-x", "15750857"]}, {"Citation": "Penson D.F., Stoddard M.L., Pasta D.J., Lubeck D.P., Flanders S.C., Litwin M.S. The Association Between Socioeconomic Status, Health Insurance Coverage, and Quality of Life in Men with Prostate Cancer. J. Clin. Epidemiol. 2001;80:350\u2013358. doi: 10.1016/S0895-4356(00)00312-7.", "ArticleIdList": ["10.1016/S0895-4356(00)00312-7", "11297885"]}, {"Citation": "White A., Coker A.L., Du X.L., Eggleston K.S., Williams M. Racial/ethnic disparities in survival among men diagnosed with prostate cancer in Texas. Cancer. 2011 doi: 10.1002/cncr.25671.", "ArticleIdList": ["10.1002/cncr.25671", "PMC3100436", "21351084"]}, {"Citation": "Ripple M.O., Henry W.F., Rago R.P., Wilding G. Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells. J. Natl. Cancer Inst. 1997 doi: 10.1093/jnci/89.1.40.", "ArticleIdList": ["10.1093/jnci/89.1.40", "8978405"]}, {"Citation": "Jones R.A., Underwood S.M., Rivers B.M. Reducing prostate cancer morbidity and mortality in African American men: Issues and challenges. Clin. J. Oncol. Nurs. 2007 doi: 10.1188/07.CJON.865-872.", "ArticleIdList": ["10.1188/07.CJON.865-872", "18063545"]}, {"Citation": "Society A.C. American Cancer Society. Cancer facts and figures 2007. Am. Cancer Soc. 2007 doi: 10.1002/hep.24172.", "ArticleIdList": ["10.1002/hep.24172"]}, {"Citation": "Morris M.J., Basch E.M., Wilding G., Hussain M., Carducci M.A., Higano C., Kantoff P., Oh W.K., Small E.J., George D., et al. Department of Defense prostate cancer clinical trials consortium: A new instrument for prostate cancer clinical research. Clin. Genitourin. Cancer. 2009 doi: 10.3816/CGC.2009.n.009.", "ArticleIdList": ["10.3816/CGC.2009.n.009", "PMC3394090", "19213669"]}, {"Citation": "Facts C. Cancer Facts & Figures 2013. Atlanta: American Cancer Society; 2013. Am. Cancer Soc. 2013 doi: 10.3322/caac.21254.", "ArticleIdList": ["10.3322/caac.21254"]}, {"Citation": "Arias E. United States life Tables, 2007. National Vital Statistics Reports; Vol 59 No 9. National Center for Health Statistics; Hyattsville, MD, USA: 2011. Natl. Vital Stat. Reports.", "ArticleIdList": ["22070012"]}, {"Citation": "Desai N., Sabanegh E., Kim T., Agarwal A. Free Radical Theory of Aging: Implications in Male Infertility. Urology. 2010 doi: 10.1016/j.urology.2009.05.025.", "ArticleIdList": ["10.1016/j.urology.2009.05.025", "19616285"]}, {"Citation": "Paschos A., Pandya R., Duivenvoorden W.C.M., Pinthus J.H. Oxidative stress in prostate cancer: Changing research concepts towards a novel paradigm for prevention and therapeutics. Prostate Cancer Prostatic Dis. 2013 doi: 10.1007/s12185-015-1880-3.", "ArticleIdList": ["10.1007/s12185-015-1880-3", "23670256"]}, {"Citation": "Szewczyk-Golec K., Tyloch J., Czuczejko J. Antioxidant defense system in prostate adenocarcinoma and benign prostate hyperplasia of elderly patients. Neoplasma. 2015 doi: 10.4149/neo_2015_015.", "ArticleIdList": ["10.4149/neo_2015_015", "25563375"]}, {"Citation": "Aggarwal B.B., Harikumar K.B. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int. J. Biochem. Cell Biol. 2009;41:40\u201359. doi: 10.1016/j.biocel.2008.06.010.", "ArticleIdList": ["10.1016/j.biocel.2008.06.010", "PMC2637808", "18662800"]}, {"Citation": "Teiten M.H., Gaascht F., Eifes S., Dicato M., Diederich M. Chemopreventive potential of curcumin in prostate cancer. Genes Nutr. 2010;5:61\u201374. doi: 10.1007/s12263-009-0152-3.", "ArticleIdList": ["10.1007/s12263-009-0152-3", "PMC2820199", "19806380"]}, {"Citation": "Shanmugam M.K., Rane G., Kanchi M.M., Arfuso F., Chinnathambi A., Zayed M.E., Alharbi S.A., Tan B.K.H., Kumar A.P., Sethi G. The multifaceted role of curcumin in cancer prevention and treatment. Molecules. 2015;20:2728\u20132769. doi: 10.3390/molecules20022728.", "ArticleIdList": ["10.3390/molecules20022728", "PMC6272781", "25665066"]}, {"Citation": "Dorai T., Gehani N., Katz A. Therapeutic potential of curcumin in human prostate cancer\u2014I. curcumin induces apoptosis in both androgen-dependent and androgen-independent prostate cancer cells. Prostate Cancer Prostatic Dis. 2000;3:84\u201393. doi: 10.1038/sj.pcan.4500399.", "ArticleIdList": ["10.1038/sj.pcan.4500399", "12497104"]}, {"Citation": "Deng G., Yu J.H., Ye Z.Q., Hu Z.Q. Curcumin inhibits the expression of vascular endothelial growth factor and androgen-independent prostate cancer cell line PC-3 in vitro. Zhonghua Nan Ke Xue. 2008;14:116\u2013121.", "ArticleIdList": ["18390174"]}, {"Citation": "Shankar S., Ganapathy S., Chen Q., Srivastava R.K. Curcumin sensitizes TRAIL-resistant xenografts: Molecular mechanisms of apoptosis, metastasis and angiogenesis. Mol. Cancer. 2008;7 doi: 10.1186/1476-4598-7-16.", "ArticleIdList": ["10.1186/1476-4598-7-16", "PMC2249593", "18226269"]}, {"Citation": "Dorai T., Cao Y.C., Dorai B., Buttyan R., Katz A.E. Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo. Prostate. 2001;47:293\u2013303. doi: 10.1002/pros.1074.", "ArticleIdList": ["10.1002/pros.1074", "11398177"]}, {"Citation": "Deeb D., Jiang H., Gao X., Hafner M.S., Wong H., Divine G., Chapman R.A., Dulchavsky S.A., Gautam S.C. Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-kappaB through suppression of IkappaBalpha phosphorylation. Mol. Cancer Ther. 2004;3:803\u2013812.", "ArticleIdList": ["15252141"]}, {"Citation": "Dorai T., Dutcher J.P., Dempster D.W., Wiernik P.H. Therapeutic potential of curcumin in prostate cancer - IV: Interference with the osteomimetic properties of hormone refractory C4-2B prostate cancer cells. Prostate. 2004;60:1\u201317. doi: 10.1002/pros.10359.", "ArticleIdList": ["10.1002/pros.10359", "15129424"]}, {"Citation": "Janane D., Orla O., Stephen B D. Curcumin Inhibits Protate Cancer Bone Metastasis by Up-Regulating Bone Morphogenic Protein-7 in Vivo. J. Cancer Ther. 2014;5:369\u2013386.", "ArticleIdList": ["PMC4060744", "24949215"]}, {"Citation": "Yang J., Ning J., Peng L., He D. Effect of curcumin on Bcl-2 and Bax expression in nude mice prostate cancer. Int. J. Clin. Exp. Pathol. 2015;8:9272\u20139278.", "ArticleIdList": ["PMC4583908", "26464676"]}, {"Citation": "Yang J., Wang C., Zhang Z., Chen X., Jia Y., Wang B., Kong T. Curcumin inhibits the survival and metastasis of prostate cancer cells via the Notch-1 signaling pathway. APMIS. 2017;125:134\u2013140. doi: 10.1111/apm.12650.", "ArticleIdList": ["10.1111/apm.12650", "28120490"]}, {"Citation": "Du Y., Long Q., Zhang L., Shi Y., Liu X., Li X., Guan B., Tian Y., Wang X., Li L., et al. Curcumin inhibits cancer-associated fibroblast-driven prostate cancer invasion through MAOA/mTOR/HIF-1alpha signaling. Int. J. Oncol. 2015;47:2064\u20132072. doi: 10.3892/ijo.2015.3202.", "ArticleIdList": ["10.3892/ijo.2015.3202", "PMC4665143", "26499200"]}, {"Citation": "Hong J.H., Ahn K.S., Bae E., Jeon S.S., Choi H.Y. The effects of curcumin on the invasiveness of prostate cancer in vitro and in vivo. Prostate Cancer Prostatic Dis. 2006;9:147\u2013152. doi: 10.1038/sj.pcan.4500856.", "ArticleIdList": ["10.1038/sj.pcan.4500856", "16389264"]}, {"Citation": "Jordan B.C., Mock C.D., Thilagavathi R., Selvam C. Molecular mechanisms of curcumin and its semisynthetic analogues in prostate cancer prevention and treatment. Life Sci. 2016 doi: 10.1016/j.lfs.2016.03.036.", "ArticleIdList": ["10.1016/j.lfs.2016.03.036", "PMC4867249", "27018446"]}, {"Citation": "Zhou D.Y., Zhao S.Q., Du Z.Y., Zheng X., Zhang K. Pyridine analogues of curcumin exhibit high activity for inhibiting CWR-22Rv1 human prostate cancer cell growth and androgen receptor activation. Oncol. Lett. 2016 doi: 10.3892/ol.2016.4536.", "ArticleIdList": ["10.3892/ol.2016.4536", "PMC4888218", "27313760"]}, {"Citation": "Wei X., Du Z.Y., Cui X.X., Verano M., Mo R.Q., Tang Z.K., Conney A.H., Zheng X., Zhang K. Effects of cyclohexanone analogues of curcumin on growth, apoptosis and NF-\u03baB activity in PC-3 human prostate cancer cells. Oncol. Lett. 2012 doi: 10.3892/ol.2012.710.", "ArticleIdList": ["10.3892/ol.2012.710", "PMC3402731", "22844370"]}, {"Citation": "Muniyan S., Chou Y.W., Ingersoll M.A., Devine A., Morris M., Odero-Marah V.A., Khan S.A., Chaney W.G., Bu X.R., Lin M.F. Antiproliferative activity of novel imidazopyridine derivatives on castration-resistant human prostate cancer cells. Cancer Lett. 2014 doi: 10.1016/j.canlet.2014.07.002.", "ArticleIdList": ["10.1016/j.canlet.2014.07.002", "PMC4150829", "25050738"]}, {"Citation": "Joseph J.D., Lu N., Qian J., Sensintaffar J., Shao G., Brigham D., Moon M., Maneval E.C., Chen I., Darimont B., et al. A clinically relevant androgen receptor mutation confers resistance to second-generation antiandrogens enzalutamide and ARN-509. Cancer Discov. 2013 doi: 10.1158/2159-8290.CD-13-0226.", "ArticleIdList": ["10.1158/2159-8290.CD-13-0226", "23779130"]}, {"Citation": "Hussain M., Corn P.G., Michaelson M.D., Hammers H.J., Alumkal J.J., Ryan C.J., Bruce J.Y., Moran S., Lee S.Y., Lin H.M., et al. Phase II study of single-agent orteronel (TAK-700) in patients with nonmetastatic castration-resistant prostate cancer and rising prostate-specific antigen. Clin. Cancer Res. 2014 doi: 10.1158/1078-0432.CCR-14-0356.", "ArticleIdList": ["10.1158/1078-0432.CCR-14-0356", "24965748"]}, {"Citation": "K\u00f6hler A., Demir \u00dc., Kickstein E., Krauss S., Aigner J., Aranda-Orgill\u00e9s B., Karagiannidis A.I., Achm\u00fcller C., Bu H., Wunderlich A., et al. A hormone-dependent feedback-loop controls androgen receptor levels by limiting MID1, a novel translation enhancer and promoter of oncogenic signaling. Mol. Cancer. 2014 doi: 10.1186/1476-4598-13-146.", "ArticleIdList": ["10.1186/1476-4598-13-146", "PMC4074869", "24913494"]}, {"Citation": "Dorai T., Gehani N., Katz A. Therapeutic potential of curcumin in human prostate cancer. II. Curcumin inhibits tyrosine kinase activity of epidermal growth factor receptor and depletes the protein. Mol. Urol. 2000;4:1\u20136.", "ArticleIdList": ["10851300"]}, {"Citation": "Nakamura K., Yasunaga Y., Segawa T., Ko D., Moul J.W., Srivastava S., Rhim J.S. Curcumin down-regulates AR gene expression and activation in prostate cancer cell lines. Int. J. Oncol. 2002;21:825\u2013830. doi: 10.3892/ijo.21.4.825.", "ArticleIdList": ["10.3892/ijo.21.4.825", "12239622"]}, {"Citation": "Tsui K.-H., Feng T.-H., Lin C.-M., Chang P.-L., Juang H.-H. Curcumin blocks the activation of androgen and interlukin-6 on prostate-specific antigen expression in human prostatic carcinoma cells. J. Androl. 2008;29:661\u2013668. doi: 10.2164/jandrol.108.004911.", "ArticleIdList": ["10.2164/jandrol.108.004911", "18676361"]}, {"Citation": "Mukhopadhyay A., Bueso-Ramos C., Chatterjee D., Pantazis P., Aggarwal B.B. Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines. Oncogene. 2001;20:7597\u20137609. doi: 10.1038/sj.onc.1204997.", "ArticleIdList": ["10.1038/sj.onc.1204997", "11753638"]}, {"Citation": "Mukhopadhyay A., Banerjee S., Stafford L.J., Xia C., Liu M., Aggarwal B.B. Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation. Oncogene. 2002;21:8852\u20138861. doi: 10.1038/sj.onc.1206048.", "ArticleIdList": ["10.1038/sj.onc.1206048", "12483537"]}, {"Citation": "Srivastava R.K., Chen Q., Siddiqui I., Sarva K., Shankar S. Linkage of curcumin-induced cell cycle arrest and apoptosis by cyclin-dependent kinase inhibitor p21/WAF1/CIP1. Cell Cycle. 2007;6:2953\u20132961. doi: 10.4161/cc.6.23.4951.", "ArticleIdList": ["10.4161/cc.6.23.4951", "18156803"]}, {"Citation": "Killian P.H., Kronski E., Michalik K.M., Barbieri O., Astigiano S., Sommerhoff C.P., Pfeffer U., Nerlich A.G., Bachmeier B.E. Curcumin inhibits prostate cancer metastasis in vivo by targeting the inflammatory cytokines CXCL1 and -2. Carcinogenesis. 2012;33:2507\u20132519. doi: 10.1093/carcin/bgs312.", "ArticleIdList": ["10.1093/carcin/bgs312", "23042094"]}, {"Citation": "Gupta S.C., Patchva S., Aggarwal B.B. Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials. AAPS J. 2013;15:195\u2013218. doi: 10.1208/s12248-012-9432-8.", "ArticleIdList": ["10.1208/s12248-012-9432-8", "PMC3535097", "23143785"]}, {"Citation": "Ide H., Tokiwa S., Sakamaki K., Nishio K., Isotani S., Muto S., Hama T., Masuda H., Horie S. Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate-specific antigen. Prostate. 2010;70:1127\u20131133. doi: 10.1002/pros.21147.", "ArticleIdList": ["10.1002/pros.21147", "20503397"]}, {"Citation": "Hsing A.W., Chokkalingam A.P., Gao Y.-T., Madigan M.P., Deng J., Gridley G., Fraumeni J.F. Allium vegetables and risk of prostate cancer: A population-based study. J. Natl. Cancer Inst. 2002;94:1648\u20131651. doi: 10.1093/jnci/94.21.1648.", "ArticleIdList": ["10.1093/jnci/94.21.1648", "12419792"]}, {"Citation": "Xiao D., Lew K.L., Kim Y.A., Zeng Y., Hahm E.R., Dhir R., Singh S.V. Diallyl trisulfide suppresses growth of PC-3 human prostate cancer xenograft in vivo in association with Bax and Bak induction. Clin. Cancer Res. 2006;12:6836\u20136843. doi: 10.1158/1078-0432.CCR-06-1273.", "ArticleIdList": ["10.1158/1078-0432.CCR-06-1273", "17121905"]}, {"Citation": "Petropoulos S.A., Fernandes \u00c2., Ntatsi G., Petrotos K., Barros L., Ferreira I.C.F.R. Nutritional value, chemical characterization and bulb morphology of Greek Garlic landraces. Molecules. 2018;23:319. doi: 10.3390/molecules23020319.", "ArticleIdList": ["10.3390/molecules23020319", "PMC6017064", "29393882"]}, {"Citation": "Rasul Suleria H.A., Sadiq Butt M., Muhammad Anjum F., Saeed F., Batool R., Nisar Ahmad A. Aqueous garlic extract and its phytochemical profile; Special reference to antioxidant status. Int. J. Food Sci. Nutr. 2012;63:431\u2013439. doi: 10.3109/09637486.2011.634786.", "ArticleIdList": ["10.3109/09637486.2011.634786", "22098476"]}, {"Citation": "Thomson M., Ali M. Garlic [Allium sativum]: A review of its potential use as an anti-cancer agent. Curr. Cancer Drug Targets. 2003;3:67\u201381. doi: 10.2174/1568009033333736.", "ArticleIdList": ["10.2174/1568009033333736", "12570662"]}, {"Citation": "Herman-Antosiewicz A., Kim Y.-A., Kim S.-H., Xiao D., Singh S. V Diallyl trisulfide-induced G2/M phase cell cycle arrest in DU145 cells is associated with delayed nuclear translocation of cyclin-dependent kinase 1. Pharm. Res. 2010;27:1072\u20131079. doi: 10.1007/s11095-010-0060-7.", "ArticleIdList": ["10.1007/s11095-010-0060-7", "PMC2873064", "20143254"]}, {"Citation": "Xiao D., Singh S.V. Diallyl trisulfide, a constituent of processed garlic, inactivates Akt to trigger mitochondrial translocation of BAD and caspase-mediated apoptosis in human prostate cancer cells. Carcinogenesis. 2006;27:533\u2013540. doi: 10.1093/carcin/bgi228.", "ArticleIdList": ["10.1093/carcin/bgi228", "16169930"]}, {"Citation": "Chandra-Kuntal K., Singh S.V. Diallyl trisulfide inhibits activation of signal transducer and activator of transcription 3 in prostate cancer cells in culture and In vivo. Cancer Prev. Res. 2010;3:1473\u20131483. doi: 10.1158/1940-6207.CAPR-10-0123.", "ArticleIdList": ["10.1158/1940-6207.CAPR-10-0123", "PMC2988081", "20959517"]}, {"Citation": "Kim S.H., Bommareddy A., Singh S.V. Garlic constituent diallyl trisulfide suppresses X-linked inhibitor of apoptosis protein in prostate cancer cells in culture and in vivo. Cancer Prev. Res. 2011;4:897\u2013906. doi: 10.1158/1940-6207.CAPR-10-0323.", "ArticleIdList": ["10.1158/1940-6207.CAPR-10-0323", "PMC3107923", "21411500"]}, {"Citation": "Yedjou C.G., Tchounwou P.B. In vitro assessment of oxidative stress and apoptotic mechanisms of garlic extract in the treatment of acute promyelocytic leukemia. J. Cancer Sci. Ther. 2012;2012:6. doi: 10.4172/1948-5956.S3-006.", "ArticleIdList": ["10.4172/1948-5956.S3-006", "PMC3705777", "23847719"]}, {"Citation": "Yedjou C., Izevbigie E., Tchounwou P. Preclinical assessment of Vernonia amygdalina leaf extracts as DNA damaging anti-cancer agent in the management of breast cancer. Int. J. Environ. Res. Public Health. 2008;5:337\u2013341. doi: 10.3390/ijerph5050337.", "ArticleIdList": ["10.3390/ijerph5050337", "PMC3699992", "19151427"]}, {"Citation": "Erasto P., Grierson D.S., Afolayan A.J. Evaluation of antioxidant activity and the fatty acid profile of the leaves of Vernonia amygdalina growing in South Africa. Food Chem. 2007;104:636\u2013642. doi: 10.1016/j.foodchem.2006.12.013.", "ArticleIdList": ["10.1016/j.foodchem.2006.12.013"]}, {"Citation": "Nwanjo H.U. Efficacy of aqueous leaf extract of vernonia amygdalina on plasma lipoprotein and oxidative status in diabetic rat models. Niger. J. Physiol. Sci. 2005;20:39\u201342.", "ArticleIdList": ["17220925"]}, {"Citation": "Adaramoye O.A., Akintayo O., Achem J., Fafunso M.A. Lipid-lowering effects of methanolic extract of Vernonia amygdalina leaves in rats fed on high cholesterol diet. Vasc. Health Risk Manag. 2008;4:235\u2013241. doi: 10.2147/VHRM.S2451.", "ArticleIdList": ["10.2147/VHRM.S2451", "PMC2464769", "18629374"]}, {"Citation": "Erasto P., Grierson D.S., Afolayan A.J. Bioactive sesquiterpene lactones from the leaves of Vernonia amygdalina. J. Ethnopharmacol. 2006;106:117\u2013120. doi: 10.1016/j.jep.2005.12.016.", "ArticleIdList": ["10.1016/j.jep.2005.12.016", "16458461"]}, {"Citation": "Tona L., Cimanga R.K., Mesia K., Musuamba C.T., De Bruyne T., Apers S., Hernans N., Van Miert S., Pieters L., Tott\u00e9 J., et al. In vitro antiplasmodial activity of extracts and fractions from seven medicinal plants used in the Democratic Republic of Congo. J. Ethnopharmacol. 2004;93 doi: 10.1016/j.jep.2004.02.022.", "ArticleIdList": ["10.1016/j.jep.2004.02.022", "15182900"]}, {"Citation": "Khlebnikov A.I., Schepetkin I.A., Domina N.G., Kirpotina L.N., Quinn M.T. Improved quantitative structure-activity relationship models to predict antioxidant activity of flavonoids in chemical, enzymatic, and cellular systems. Bioorg. Med. Chem. 2007;15:1749\u20131770. doi: 10.1016/j.bmc.2006.11.037.", "ArticleIdList": ["10.1016/j.bmc.2006.11.037", "PMC2013303", "17166721"]}, {"Citation": "Johnson W., Tchounwou P.B., Yedjou C.G. Therapeutic mechanisms of vernonia amygdalina delile in the treatment of prostate cancer. Molecules. 2017;22:1594. doi: 10.3390/molecules22101594.", "ArticleIdList": ["10.3390/molecules22101594", "PMC5661957", "28937624"]}, {"Citation": "Lowe H.I.C., Daley-Beckford D., Toyang N.J., Watson C., Hartley S., Bryant J. The anti-cancer activity of Vernonia divaricata Sw against leukaemia, breast and prostate cancers in vitro. West. Indian Med. J. 2014 doi: 10.7727/wimj.2013.232.", "ArticleIdList": ["10.7727/wimj.2013.232", "PMC4663936", "25429469"]}, {"Citation": "Izevbigie E.B. Discovery of water-soluble anticancer agents (edotides) from a vegetable found in Benin City, Nigeria. Exp. Biol. Med. (Maywood). 2003;228:293\u2013298. doi: 10.1177/153537020322800308.", "ArticleIdList": ["10.1177/153537020322800308", "12626774"]}]}], "History": [{"Year": "2018", "Month": "11", "Day": "19"}, {"Year": "2019", "Month": "1", "Day": "2"}, {"Year": "2019", "Month": "1", "Day": "29"}, {"Year": "2019", "Month": "2", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "2", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "3", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "2", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["30720759", "PMC6412894", "10.3390/nu11020336", "nu11020336"]}}]}